Resveratrol, a sirtuin 1 activator, increases IL-6 production by peripheral blood mononuclear cells of patients with knee osteoarthritis

Clinical Epigenetics

Volumn 5, Issue 1, 2013, Pages

  Wendling, Daniel ^a,b   Abbas, Wasim ^b   Godfrin Valnet, Marie ^a   Guillot, Xavier ^a   Khan, Kashif Aziz ^b   Cedoz, Jean Pierre ^a   Baud, Lucile ^b   Prati, Clément ^a   Herbein, Georges ^a,b  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

IL 6; Osteoarthritis; PBMCs; Resveratrol; Sirtuin 1

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN C; RESVERATROL; SIRTUIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ISOLATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; EX VIVO STUDY; FLUOROMETRY; HUMAN; HUMAN CELL; KNEE OSTEOARTHRITIS; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; UPREGULATION;

EID: 84893806758     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/1868-7083-5-10     Document Type: Article

References (28)

1. Reynard LN, Loughlin J: Genetics and epigenetics of osteoarthritis. Maturitas 2012, 71:200-204.
2. Gabay O, Sanchez C: Epigenetics, sirtuins and osteoarthritis. Joint Bone Spine 2012, 79:570-573.
3. Herbein G, Wendling D: Histone deacetylases in viral infections. Clin Epigenetics 2010, 1:13-24.
4. Taylor DM, Maxwell MM, Luthi-Carter R, Kazantsev AG: Biological and potential therapeutic roles of sirtuin deacetylases. Cell Mol Life Sci 2008, 65:4000-4018.
5. Zeng L, Chen R, Liang F, Tsuchiya H, Murai H, Nakahashi T, Iwai K, Takahashi T, Kanda T, Morimoto S: Silent information regulator, Sirtuin 1, and age-related diseases. Geriatr & Gerontol Int 2009, 9:7-15.
6. Gabay O, Oppenhiemer H, Meir H, Zaal K, Sanchez C, Dvir-Ginzberg M: Increased apoptotic chondrocytes in articular cartilage from adult heterozygous SirT1 mice. Ann Rheum Dis 2012, 71: 613-616.
7. Takayama K, Ishida K, Matsushita T, Fujita N, Hayashi S, Sasaki K, Tei K, Kubo S, Matsumoto T, Fujioka H, Kurosaka M, Kuroda R: SIRT1 regulation of apoptosis of human chondrocytes. Arthritis Rheum 2009, 60:2731-2740.
8. Gagarina V, Gabay O, Dvir-Ginzberg M, Lee EJ, Brady JK, Quon MJ, Hall DJ: SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis Rheum 2010, 62:1383-1392.
9. Fujita N, Matsushita T, Ishida K, Kubo S, Matsumoto T, Takayama K, Kurosaka M, Kuroda R: Potential involvement of SIRT1 in the pathogenesis of osteoarthritis through the modulation of chondrocyte gene expressions. J Orthop Res 2011, 29:511-515.
10. Dvir-Ginzberg M, Gagarina V, Lee EJ, Booth R, Gabay O, Hall DJ: Tumor necrosis factor alpha-mediated cleavage and inactivation of SirT1 in human osteoarthritic chondrocytes. Arthritis Rheum 2011, 63:2363-2373.
11. Villalba JM, Alcain FJ: Sirtuin activators and inhibitors. Biofactors 2012, 38:349-359.
12. Lei M, Wang JG, Xiao DM, Fan M, Wang DP, Xiong JY, Chen Y, Ding Y, Liu SL: Resveratrol inhibits interleukin 1β-mediated inducible nitric oxide synthase expression in articular chondrocytes by activating SIRT1 and thereby suppressing nuclear factor-κB activity. Eur J Pharmacol 2012, 674:73-79.
13. Wang J, Gao JS, Chen JW, Li F, Tian J: Effect of resveratrol on cartilage protection and apoptosis inhibition in experimental osteoarthritis of rabbit. Rheumatol Int 2012, 32:1541-1548.
14. Csiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang H, Losonczy G, Pearson K, de Cabo R, Zhang C, Ungvari Z: Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 2009, 297:H13-H20.
15. Zhu X, Liu Q, Wang M, Liang M, Yang X, Xu X, Zou H, Qiu J: Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts. PLoS One 2011, 6:e27081.
16. Fusco S, Maulucci G, Pani G: Sirt1: def-eating senescence? Cell Cycle 2012, 11:4135-4146.
17. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW: Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004, 23:2369-2380. (Pubitemid 38954844)
18. Ashburner BP, Westerheide SD, Baldwin AS Jr: The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 2001, 21:7065-7077. (Pubitemid 32916079)
19. Chae HJ, Ha KC, Lee GY, Yang SK, Yun KJ, Kim EC, Kim SH, Chae SW, Kim HR: Interleukin-6 and cyclic AMP stimulate release of cathepsin B in human osteoblasts. Immunopharmacol Immunotoxicol 2007, 29:155-172.
20. Gabay O, Sanchez C, Dvir-Ginzberg M, Gagarina V, Zaal KJ, Song Y, He XH, McBurney MW: Sirtuin 1 enzymatic activity is required for cartilage homeostasis in vivo in a mouse model. Arthritis Rheum 2013, 65:159-166.
21. Kotas ME, Gorecki MC, Gillum MP: Sirtuin-1 is a nutrient-dependent modulator of inflammation. Adipocyte 2013, 2:113-118.
22. Hou X, Xu S, Maitland-Toolan KA, Sato K, Jiang B, Ido Y, Lan F, Walsh K, Wierzbicki M, Verbeuren TJ, Cohen RA, Zang M: SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 2008, 283:20015-20026.
23. Fernandes CA, Fievez L, Neyrinck AM, Delzenne NM, Bureau F, Vanbever R: Sirtuin inhibition attenuates the production of inflammatory cytokines in lipopolysaccharide-stimulated macrophages. Biochem Biophys Res Commun 2012, 420:857-861.
24. Niederer F, Ospelt C, Brentano F, Hottiger MO, Gay RE, Gay S, Detmar M, Kyburz D: SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Ann Rheum Dis 2011, 70:1866-1873.
25. Roger T, Lugrin J, Le Roy D, Goy G, Mombelli M, Koessler T, Ding XC, Chanson AL, Reymond MK, Miconnet I, Schrenzel J, François P, Calandra T: Histone deacetylase inhibitors impair innate immune response to Toll-like receptor agonists and to infection. Blood 2011, 117:1205-1217.
26. Mombelli M, Lugrin J, Rubino I, Chanson AL, Giddey M, Calandra T, Roger T: Histone deacetylase inhibitors impair antibacterial defenses of macrophages. J Infect Dis 2011, 204: 1367-1374.
27. Kang OH, Jang HJ, Chae HS, Oh YC, Choi JG, Lee YS, Kim JH, Kim YC, Sohn DH, Park H, Kwon DY: Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-κB and MAPK. Pharmacol Res 2009, 59:330-337.
28. Dvir-Ginzberg M, Steinmeyer J: Towards elucidating the role of Sirt1 in osteoarthritis. Front Biosci 2013, 18:343-355.